B
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT • NASDAQ
BridgeBio Oncology Therapeutics, Inc. Common Stock is a publicly traded company on NASDAQ, led by Eli Wallace, with a market cap of $1.0B. As of Q3 2025, 72% of shares are held by 40 institutional investors, with Cormorant Asset Management, LLC as the largest holder at 22.57%.
Chief Executive OfficerEli Wallace
Market Cap$1.0B
Overview
Overview of institutional ownership in BBOT as of Q3 2025 with a market cap of $917.1M
All Institutions
- Institutions
- 40
- Value Held
- $657.5M
- Shares Held
- 56.8M
- Avg Position
- $16.4M
- Median Position
- $5.6M
Hedge Funds
- Hedge Funds
- 17
- Value Held
- $403.6M
- Shares Held
- 34.9M
- Avg Position
- $23.7M
- Median Position
- $5.3M
Ownership Breakdown
Based on market cap of $917.1M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in BBOT as of Q3 2025
| Institution | Position Value |
|---|---|
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | $207.0M 16.13% of portfolio |
 DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | $56.6M 0.94% of portfolio |
 Omega Fund Management Inc. Venture Capital | $38.1M 17.13% of portfolio |
 WELLINGTON MANAGEMENT CO LLP Long Only Manager | $34.3M 0.01% of portfolio |
 EcoR1 Capital, LLC Hedge Fund•Sector | $32.7M 1.57% of portfolio |
 Alphabet Inc. Institution | $32.7M 1.36% of portfolio |
E Enavate Sciences GP, LLC Institution | $30.4M 9.29% of portfolio |
 CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $29.4M 0.02% of portfolio |
B BlackRock, Inc. Institution | $23.7M 0.00% of portfolio |
N Novo A/S Institution | $22.7M 1.49% of portfolio |
Net Capital Flow
Institutional buying and selling activity for BBOT in Q3 2025
- Traded
- +$657.5M
- Buyers
- 40
- Sellers
- 0
- Total Bought
- +$657.5M
- Total Sold
- −-
- Avg Position
- $16.0M
Biggest Buyers
| Institution | Net Bought |
|---|---|
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | +$207.0M +17.9M shares |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | +$56.6M +4.9M shares |
Omega Fund Management Inc. Venture Capital | +$38.1M +3.3M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$34.3M +3.0M shares |
Alphabet Inc. Institution | +$32.7M +2.8M shares |
EcoR1 Capital, LLC Hedge Fund•Sector | +$32.7M +2.8M shares |
E Enavate Sciences GP, LLC Institution | +$30.4M +2.6M shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$29.4M +2.5M shares |
B BlackRock, Inc. Institution | +$23.7M +2.0M shares |
N Novo A/S Institution | +$22.7M +2.0M shares |
Biggest Sellers
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Entry and Exit Activity
Institutions that initiated new positions or completely exited BBOT in Q3 2025
- New Positions
- 41
- New Value
- $657.5M
- Exited Positions
- 0
- Exited Value
- -
New Positions
| Institution | Position Value |
|---|---|
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | $207.0M 17.9M shares |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | $56.6M 4.9M shares |
Omega Fund Management Inc. Venture Capital | $38.1M 3.3M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $34.3M 3.0M shares |
Alphabet Inc. Institution | $32.7M 2.8M shares |
EcoR1 Capital, LLC Hedge Fund•Sector | $32.7M 2.8M shares |
E Enavate Sciences GP, LLC Institution | $30.4M 2.6M shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $29.4M 2.5M shares |
B BlackRock, Inc. Institution | $23.7M 2.0M shares |
N Novo A/S Institution | $22.7M 2.0M shares |
Exited Positions
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Options Activity
Institutions with the largest Call and Put options positions in BBOT as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with BBOT as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
Omega Fund Management Inc. Venture Capital | 17.13% $38.1M |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | 16.13% $207.0M |
E Enavate Sciences GP, LLC Institution | 9.29% $30.4M |
 Octagon Capital Advisors LP Hedge Fund•Sector | 1.90% $12.1M |
 Laurion Capital Management LP Hedge Fund•Multi-Strategy | 1.78% $12.1M |
EcoR1 Capital, LLC Hedge Fund•Sector | 1.57% $32.7M |
N Novo A/S Institution | 1.49% $22.7M |
A Aisling Capital Management LP Private Equity | 1.43% $6.5M |
Alphabet Inc. Institution | 1.36% $32.7M |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | 0.94% $56.6M |
Hedge Fund Spotlight
Discover hedge funds investing in BBOT
C
Cormorant Asset Management, LLC
Hedge Fund • Long/Short
Portfolio ManagerBihua Chen
- Portfolio Value
- $1.3B
- Positions
- 35
- Last Reported
- Q3 2025
Sector Allocation
B
Position in BridgeBio Oncology Therapeutics, Inc. Common Stock
- Market Value
- $207.0M
- Shares Held
- 17.9M
- Portfolio Weight
- 16.13%
- Owned Since
- 2025-Q3
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Unknown Unknown | $207.0M | 16.13% | |
Biotechnology Healthcare | $118.5M | 9.23% | |
Unknown Unknown | $94.8M | 7.39% |
